Oxidative stress in kidney transplant patients

Transplantation

Volumn 76, Issue 10, 2003, Pages 1474-1478

  Campise, Mariarosaria ^a   Bamonti, Fabrizia ^b   Novembrino, Cristina ^b   Ippolito, Silvia ^b   Tarantino, Antonio ^a   Cornelli, Umberto ^c   Lonati, Silvia ^b   Cesana, Bruno M ^a   Ponticelli, Claudio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; REACTIVE OXYGEN METABOLITE; THIOL GROUP;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ERYTHROCYTE LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HEMATOCRIT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL;

ADULT; CADAVER; CREATININE; ERYTHROCYTES; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HEMATOCRIT; HOMOCYSTEINE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE DONORS;

EID: 0344584337     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000090344.61975.F0     Document Type: Article

References (30)

1. Bryan RN, Cai J, Burke G, et al. Prevalence and anatomic characteristics of infarct-like lesion on MR images of middle-aged adults: The atherosclerosis risk in communities study. AJNR Am J Neuroradiol 1999; 20: 1273.
2. Friedman AN, Rosenberg IH, Selhub J, et al. Hyperhomocysteinemia in renal transplant recipients. Am J Transplant 2002; 2: 308.
3. McGrath LT, Treacy R, McClean E, et al. Oxidative stress in cyclosporin and azathioprine treated renal transplant patients. Clin Chim Acta 1997; 8: 264.
4. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52: 10.
5. Trotti R, Carratelli M, Barbieri M, et al. Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease. Haematologica 2001; 86: 85.
6. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1): 31.
7. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985.
8. Ponticelli C, Montagnino G, Aroldi A, et al. Hypertension after renal transplantation. Am J Kidney Dis 1993; 21(2): 73.
9. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: Scientific review. JAMA 2002; 288: 1388.
10. Fellstrom B. Risk factors for and management of post-transplantation cardiovascular disease. BioDrugs 2001; 15: 261.
11. Cosio FG, Falkenhain ME, Pesavento TE, et al. Patient survival after transplantation: II. The impact of smoking. Clin Transplant 1999; 13: 336.
12. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001; 72(6): S5.
13. Cosio FG, Alamir A, Falkenhain ME, et al. Patient survival after renal transplantation: I. The impact of dialysis pretransplant. Kidney Int 1998; 53: 757.
14. Montagnino G, Tarantino A, Maccario M, et al. Long-term results with cyclosporine monotherapy in renal transplant patients: A multivariate analysis of risk factors. Am J Kidney Dis 2000; 35: 1135.
15. Montagnino G, Tarantino A, Cesana B, et al. Prognostic factors of long-term allograft survival in 632 CyA-treated recipients of a primary renal transplant. Transpl Int 1997; 10: 268.
16. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia, an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149.
17. Ducloux D, Fournier V, Rebibou JM, et al. Hyperhomocysteinemia in renal transplant recipients with and without cyclosporine. Clin Nephrol 1998; 49: 232.
18. Bostom AG, Kronenberg F, Gohh RY, et al. Chronic renal transplantation: A model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis 2001; 156: 227.
19. Mansoor MA, Bergmark C, Svardal AM, et al. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease: Homocysteine and peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995; 15: 232.
20. Bostom AG, Gohh RY, Beaulieu AJ, et al. Treatment of hyperhomocysteinemia in renal transplant recipients: A randomized, placebo-controlled trial. Ann Intern Med 1997; 127: 1089.
21. Bertoni E, Rosati A, Marcucci R, et al. Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease. Transplant, Proc 2001; 33: 3682.
22. Sarnak MJ, Tighiouart H, Manjunath G et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk Communities (AIRC) study. J Am Coll Cardiol 2002; 40: 27.
23. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53.
24. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge. Kidney Int 2002; 64: S35.
25. Rigatto C, Parfrey P, Foley R, et al. Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002; 13: 1084.
26. Harnett JD, Kent GM, Foley RN, et al. Cardiac function and hematocrit level. Am J Kidney Dis 1995; 25(1): S3.
27. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996; 28: 506.
28. Zhou KJ, Vaziri ND, Wang XQ, et al. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 2002; 300(3): 762.
29. Vaziri ND, Ni Z, Oveisi F, et al. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2002; 36(6): 957.
30. Albrecht EW, Stegeman CA, Tiebosch AT, et al. Expression of inducible endothelial nitric oxide synthases, formation of peroxynitrite and reactive oxygen species in human chronic renal transplant failure. Am J Transplant 2002; 2(5): 448.